ICU Medical 

$143.41
14
+$1.21+0.85% Today

Statistics

Day High
145.25
Day Low
141.36
52W High
160.29
52W Low
107
Volume
10,393,428
Avg. Volume
-
Mkt Cap
3.54B
P/E Ratio
73.52
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.28
1.56
1.83
2.11
Expected EPS
1.913333
Actual EPS
N/A

Financials

0.03%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.46BRevenue
1.46MNet Income

Analyst Ratings

165.50Average Price Target
The highest estimate is 170.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ICUI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Becton Dickinson
BDX
Mkt Cap40.3B
Becton, Dickinson and Company offers a wide range of medical supplies, devices, laboratory equipment, and diagnostic products, competing directly with ICU Medical's infusion therapy and related medical products.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation specializes in the development, manufacturing, and marketing of medical devices that are used in various interventional medical specialties, overlapping with ICU Medical's product offerings.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc manufactures and sells device-based medical therapies and services, including those for drug delivery systems, competing in areas similar to ICU Medical.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson operates in the healthcare field, offering products and services in segments such as medical devices that compete with ICU Medical's offerings.
Abbott Laboratories
ABT
Mkt Cap153.59B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including vascular and other medical devices that compete with ICU Medical.
Baxter International
BAX
Mkt Cap10.77B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products that compete with ICU Medical's infusion systems and injectables.
Cardinal Health
CAH
Mkt Cap52.43B
Cardinal Health, Inc. is a global, integrated healthcare services and products company, offering customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide. Its medical segment offers products that compete with ICU Medical.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. designs, manufactures, and markets orthopedic reconstructive products; sports medicine, biologics, extremities, and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Its wide range of medical devices places it in competition with ICU Medical in certain segments.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation specializes in medical and surgical equipment and neurotechnology and spine products, competing in the medical device market alongside ICU Medical.

About

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Show more...
CEO
Mr. Vivek Jain
Employees
15000
Country
United States
ISIN
US44930G1076

Listings

0 Comments

Share your thoughts

FAQ

What is ICU Medical stock price today?
The current price of ICUI is $143.41 USD — it has increased by +0.85% in the past 24 hours. Watch ICU Medical stock price performance more closely on the chart.
What is ICU Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ICU Medical stocks are traded under the ticker ICUI.
Is ICU Medical stock price growing?
ICUI stock has risen by +4.1% compared to the previous week, the month change is a +20.55% rise, over the last year ICU Medical has showed a +8.39% increase.
What is ICU Medical market cap?
Today ICU Medical has the market capitalization of 3.54B
When is the next ICU Medical earnings date?
ICU Medical is going to release the next earnings report on August 10, 2026.
What were ICU Medical earnings last quarter?
ICUI earnings for the last quarter are 1.97 USD per share, whereas the estimation was 1.75 USD resulting in a +12.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ICU Medical revenue for the last year?
ICU Medical revenue for the last year amounts to 4.46B USD.
What is ICU Medical net income for the last year?
ICUI net income for the last year is 1.46M USD.
How many employees does ICU Medical have?
As of June 15, 2026, the company has 15,000 employees.
In which sector is ICU Medical located?
ICU Medical operates in the Health & Wellness sector.
When did ICU Medical complete a stock split?
The last stock split for ICU Medical was on March 18, 2002 with a ratio of 3:2.
Where is ICU Medical headquartered?
ICU Medical is headquartered in San Clemente, United States.